Trial intelligence / Profile preview

Pharmacokinetics of Colistin in Critically-ill Patients With AKI on SLED

NCT05586438Phase 4Completed

Sponsor
Mahidol University
Start
Oct 2021
Primary completion
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of colistimethate sodium in bacterial infection, sponsored by Mahidol University. Primary endpoints: Area under the concentration-time curve at 24 hours and Maximum Plasma Concentration at 24 hours. Started Oct 2021; status: completed.

02

Drugs

colistimethate sodium
03

Conditions

bacterial infection

Beyond the preview

Go deeper on NCT05586438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05586438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call